Details for New Drug Application (NDA): 207261
✉ Email this page to a colleague
The generic ingredient in ESTRADIOL AND NORETHINDRONE ACETATE is estradiol; norethindrone acetate. There are seventy-five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the estradiol; norethindrone acetate profile page.
Summary for 207261
Tradename: | ESTRADIOL AND NORETHINDRONE ACETATE |
Applicant: | Xiromed |
Ingredient: | estradiol; norethindrone acetate |
Patents: | 0 |
Pharmacology for NDA: 207261
Mechanism of Action | Estrogen Receptor Agonists |
Suppliers and Packaging for NDA: 207261
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ESTRADIOL AND NORETHINDRONE ACETATE | estradiol; norethindrone acetate | TABLET;ORAL | 207261 | ANDA | Mylan Pharmaceuticals Inc. | 0378-7294 | 0378-7294-53 | 3 POUCH in 1 CARTON (0378-7294-53) / 1 BLISTER PACK in 1 POUCH (0378-7294-85) / 28 TABLET in 1 BLISTER PACK |
ESTRADIOL AND NORETHINDRONE ACETATE | estradiol; norethindrone acetate | TABLET;ORAL | 207261 | ANDA | Mylan Pharmaceuticals Inc. | 0378-7295 | 0378-7295-53 | 3 POUCH in 1 CARTON (0378-7295-53) / 1 BLISTER PACK in 1 POUCH (0378-7295-85) / 28 TABLET in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG;0.1MG | ||||
Approval Date: | Feb 10, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG;0.5MG | ||||
Approval Date: | Feb 10, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription